In oral evidence to the Inquiry, Dr Brian McClelland explained that ALT levels was only a small element of his proposal for a comprehensive study.
Chronology Information
Date:
Chapter/issue
Hepatitis C Surrogate Screening
Key Person(s)
Dr David Brian Lorimer McClelland